Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$48.19 USD
-1.53 (-3.08%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $48.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$48.19 USD
-1.53 (-3.08%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $48.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Zacks News
Agios Pharmaceuticals (AGIO) Q4 Earnings: What's in Store?
by Zacks Equity Research
Agios Pharmaceuticals, Inc. (AGIO) is scheduled to report fourth-quarter and full-year 2016 results on Feb 16.
Falling Earnings Estimates Signal Weakness Ahead for Agios Pharmaceuticals (AGIO)
by Zacks Equity Research
Agios Pharmaceuticals (AGIO) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.
Agios Stops Development of PKR Activator AG-519, Stock Falls
by Zacks Equity Research
Shares of Agios (AGIO) tanked 19.4% after the company decided to discontinue the development of its PKR activator, AG-519.
A Company's First Profit Can Mean Big Profits to Investors
by Kevin Matras
Kevin Matras screens for companies showing their 'first' profit, and explains why they are ones to watch. Highlighted stocks include OPHT, XNPT, OSUR, INCY and AGIO.